Faster than the doctor, but equally meticulous and free of charge: the Bern computer rogram BRaTumIA for the recognition of malignant brain tumours is proving to be an international hit.
The fully automatic computer program requires a maximum of 10 minutes per patient for the analysis of the magnetic resonance image of a brain tumour. A doctor requires between 30 and 60 minutes, however.
A screenshot of BraTumIA in action.
As the first software worldwide to do so, BRaTumIA also examines the tumour on a three dimensional basis without the need for human support, a task a doctor would take a far longer time to complete, and with a higher risk of error. As a result, manual daily hospital measurements are now only
occurring on two levels.
The program was developed and clinically tested by a team of doctors and engineers from the Bern University Hospital and the Institute for Surgical Technology and Biomechanics (ISTB) at the University of Bern, under the leadership of professors Roland Wiest (University Institute for Neuroradiology) and Mauricio Reyes (ISTB).
Analysis Down to the Tiniest Detail
BraTumIA provides Neuroradiologists with the optimum support in their analysis. The software compares the patient's MRI images with all of the previously gathered statistical data and determines the tissue structures of the malignant tumour right down to the tiniest detail. Prof. Roland Wiest, Neuroradiologist and Leader of the Support Centre of Advanced Neuroimaging at the Bern University Hospital:
"The precision segmenting of the tumour tissue is enabling us to use the image information to optimise the treatment on an ever more precise basis. This is hugely important, as new treatment strategies for gliomas - malignant tumours - can receive exact information on the growth data
concerning the tumours."
Data Mining: Learning Software
It is in this context that BraTumIA has joined the medical data mining trend. Similar to conventional data mining, in which data regarding customers' buying and reading habits are gathered in the internet, the software consistently improves through the constant gathering of new statistical data. BraTumIA is currently the focus of considerable international attention: the Washington Post used the software at the beginning of October to demonstrate data mining in the analytical medical sector - in international comparisons, the software has consistently achieved a top three position in terms of its measuring accuracy.
The possibility of being able to continuously 'feed' the software with new statistical data is decisive for future brain tumour patients: when doctors analyse MRI images manually, analytical errors are theoretically possible in several different directions. The software, however, only makes analytical errors in the same direction, if at all. Doctors can check any such errors on a quick and targeted basis and reduce them to the minimum.
Soon to be Available for MS and Strokes
The intensive collaboration of the engineers and doctors in the development of BraTumIA could soon be benefitting to patients suffering from multiple sclerosis (MS) and those who have suffered stroke. The research group is currently working at full speed on two further versions of the software.
With MS patients, BraTumIA is set to provide precise analyses of inflamed brain tissue in the white brain matter (plaques). With stroke patients the software will serve the purpose of risk analysis: In the immediate aftermath of a stroke it recognises which parts of the brain are likely to remain damaged subsequent to treatment. In this task, BraTumIA also makes use of clinically gathered data.
The research on the computer supported analysis using BraTumIA at the Bern University Hospital and the University of Bern is being supported by the European Union, the Swiss National Fund and the Bern and Swiss Cancer League.
Martina Leser | Universitätsspital Bern
Medica 2018: New software for a more efficient planning of minimally invasive surgery
06.11.2018 | Technische Universität Kaiserslautern
SwRI improves structural health monitoring with magnetostrictive transducer
30.10.2018 | Southwest Research Institute
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
13.11.2018 | Life Sciences
13.11.2018 | Life Sciences
13.11.2018 | Awards Funding